CONMED Corporation Announces Quarterly Cash Dividend

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021, to shareholders of record as of September 15, 2021. This decision reflects the company’s commitment to returning value to shareholders amidst ongoing challenges, including those presented by the COVID-19 pandemic. CONMED specializes in medical technology, offering surgical devices for minimally invasive procedures across various medical fields.

Positive

• Declared a quarterly cash dividend of $0.20 per share.
• Demonstrates commitment to returning value to shareholders.

Negative

• Risks related to COVID-19 impacting surgeries and operational volumes.
• Potential supply chain disruptions affecting business performance.

CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021 to all shareholders of record as of September 15, 2021.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2020 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210812005568/en/

FAQ

What is the dividend amount for CNMD?

The dividend amount declared by CONMED Corporation is $0.20 per share.

When is the dividend payment date for CNMD?

The dividend payment date for CNMD is October 5, 2021.

What is the record date for CNMD's dividend?

The record date for CNMD's dividend is September 15, 2021.

How often does CNMD pay dividends?

CONMED Corporation typically pays dividends on a quarterly basis.

What risks does CNMD face that could impact its dividends?

CNMD faces risks from COVID-19, including deferral of surgeries and disruptions in supply chain.